The NPM1-mutated AML is classified as a distinct entity in the 2022 World Health Organization (WHO 2022) and European Leukemia Network (ELN 2022) classifications of myeloid neoplasms [1,2,3]. The gene discussed is NPM1; the disease is acute myeloid leukemia.